Trump said he would be looking over the next four weeks at tariffs on automobiles, pharmaceuticals and computer chips. Earlier this month, Trump paused 25% tariffs he’d planned to impose on ...

Global private equity firms Blackstone, Brookfield and Warburg Pincus are in talks to acquire a majority stake in Hyderabad-based Gland Pharma Ltd from China’s Shanghai Fosun Pharmaceutical Co ...

Nifty pharma falls today, February 19: The three out of the major five losers in the Nifty 50 were pharmaceutical stocks. (Image: Freepik) The Pharma stocks took the back seat in the Nifty 50 on ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

(Image/Freepik) The US’ threat to impose reciprocal tariff from April 2 on Indian exports has received mixed reaction from the domestic pharma sector. A section of the industry are hoping for ...

Pila Pharma AB (PILA) concluded its fourth-quarter earnings call for 2024, highlighting its ongoing research and development efforts, particularly in obesity and diabetes treatment. The company's ...

Driving innovation in obesity with differentiated mid- to late-stage pipeline “2024 was a transformational year for Zealand Pharma with positive data across our mid- to late-stage obesity ...

"2024 was a transformational year for Zealand Pharma with positive data across our mid- to late-stage obesity pipeline and significant capital raised to further invest in our pipeline and the ...

To participate, please dial one of the following numbers and ask to join the Verona Pharma call: +1-800-836-8184 for callers in the United States +1-646-357-8785 for international callers A live ...

In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other firms that soared on Friday. Wall Street finished mixed anew on Friday ...

This disclosure contains information that EQL Pharma is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication ...